27/04/2026
She Woke Up at 1:43 AM to a Phone Call That Changed Chemistry Forever.
The voice on the other end told Carolyn Bertozzi she had fifty minutes. Fifty minutes to collect herself before her life changed completely.
It was 1:43 in the morning. October 5, 2022. The Nobel Committee was calling to tell her she'd won the Nobel Prize in Chemistry.
At fifty-five years old, Bertozzi had spent decades chasing what seemed impossible: watching molecules work inside living cells without the cells even noticing.
The problem had haunted biochemists for generations. Every time scientists tried to study what was happening inside cells, their tools interfered with the very processes they were trying to observe. It was like trying to measure the speed of a car by throwing bricks at it.
Bertozzi approached it differently.
In the late 1990s and early 2000s, she invented chemical reactions so selective, so perfectly tuned, that they could happen right inside a living organism without disrupting a single natural process. She called them bioorthogonal reactions. Bioorthogonal—meaning the chemistry exists in its own lane, completely independent of the cell's normal chemistry.
The term itself, which Bertozzi coined in 2003, says it all: chemistry that doesn't interact with biology.
Think about what that means. You can tag a specific protein with a fluorescent marker and watch it move through a living brain. You can track how cancer cells disguise themselves from the immune system—in real time, as it's actually happening. You can design drugs that only activate when they reach their exact target inside a tumor.
Before bioorthogonal chemistry, scientists were taking snapshots of dead tissue and guessing. Now they had a window into living biology that didn't fog up the glass.
The breakthrough grew from Bertozzi's fascination with glycans—complex sugar molecules that coat cell surfaces. They're one of the key building blocks of life. And one of the least understood, partly because they're incredibly hard to study.
Bertozzi had an idea: What if she could attach fluorescent tags to these sugar molecules so she could literally see where they went in live cells?
The challenge wasn't attaching the tag. It was attaching it without interfering with what the sugar—and every other molecule in the cell—was supposed to be doing.
So she built reactions that were chemically invisible to living systems. Reactions that could happen surrounded by billions of other molecules and still find their targets with perfect precision.
It was like inserting a single thread into a tapestry without pulling or disturbing any of the existing threads.
The applications exploded.
Researchers could finally see diseases as they actually happened. Cancer treatments became more precise. One company she advises now has clinical trials underway using bioorthogonal chemistry to release toxic drugs locally in tumor environments—doing the chemical reaction inside the patient's body as the delivery mechanism.
Another company she cofounded, Redwood Bioscience, developed antibody-drug conjugates using her methods. Multiple candidates are in clinical testing.
There are vaccine conjugates in Phase II trials. Better diagnostic tests for infectious diseases, including a fast point-of-care tuberculosis test her lab helped develop in 2018.
Scientists could ask questions about living biology that had been unanswerable before.
The morning the Nobel Committee called, Bertozzi was told not to share the news outside her tightest inner circle. The first person she called was her father.
William Bertozzi is ninety-one now, a retired physics professor from MIT. "He was just overjoyed," Carolyn said. "And then he called my sisters for me, and we've been texting. One of my sisters and my dad watched it live."
Science was in her blood. She grew up immersed in it—summer camps at MIT, summer jobs in labs. She seriously considered a career in music (she'd won awards for compositions in high school and played in bands at Harvard with future Rage Against the Machine guitarist Tom Morello). But math and science won out.
As a Harvard sophomore, she discovered organic chemistry and felt the thrill of building molecules.
Now, twenty-five years into her career, she'd built something bigger than molecules. She'd built an entire field.
"I've had a lot of impact," Bertozzi said after winning. "So I'm the vehicle through which the spotlight gets cast onto the field and then also onto all the amazing students and postdocs that I've had over a twenty-five-year career."
More than 250 undergraduates, graduate students, and postdoctoral fellows have trained in her lab.
"You could tell that momentous science was happening in her lab," said Fred Tomlin, a former graduate student. "Not only did bioorthogonal chemistry create an entirely new field of research, but over time, she shaped that field to directly benefit humanity."
Bertozzi talks about her work with infectious enthusiasm. Chemistry, to her, is a tool for people who want real impact. Not abstract impact. Real solutions for cancer patients. Real diagnostic tests that work. Real drugs that reach their targets.
She became the eighth woman ever to win the Nobel Prize in Chemistry.
And even after only a few hours to reflect on becoming a Nobel laureate, she was already thinking strategically. "I'm the same person I was at 1 a.m.," she said, "but I'm realizing that my voice now has a platform, and I'm thinking about how to use that."
The woman who taught molecules to work undercover inside living cells had unlocked one of science's most powerful tools.
And she wasn't done yet.
